Cigarette smoke modulates methylation levels of LEF1-AS1 and impedes its expression: An experimental study
- PMID: 40321723
- PMCID: PMC12046985
- DOI: 10.18332/tid/203507
Cigarette smoke modulates methylation levels of LEF1-AS1 and impedes its expression: An experimental study
Abstract
Introduction: Cigarette smoke (CS) contains carcinogenic substances and influences genetic regulation and epigenetic modifications, such as DNA methylation. It plays a role in the development of various cancers, including colon, bladder, lung cancer, and leukemia. Long non-coding RNAs play a significant role in controlling several pathways in the cell, including lymphoid enhancer-binding factor 1 antisense RNA 1 (LEF1-AS1), which is found overexpressed in lung, oral, glioblastoma, and colon cancers and downregulated in leukemias. We investigated the impact of CS on DNA methylation of the promoter region of LEF1-AS1 as well as its expression in endothelial cells.
Methods: This experimental study was designed to investigate the effects of cigarette smoke on the methylation status of the promoter region of LEF1-AS1 in smoker and non-smoker samples and its expression in relevant cell models. To measure the alternations of DNA methylation, extracted DNA samples from 64 male subjects (32 smokers and 32 non-smokers) were bisulfite-treated and amplified using polymerase chain reaction (PCR) with methylation-specific PCR primers. Furthermore, to define the impact of CS on LEF1-AS1 expression, human umbilical vein endothelial cells (HUVECs) were fed with media containing CS for 3 and 6 hours. The expression analysis of LEF1-AS1 was performed using the GTEx (Genotype-Tissue Expression) database, including an assessment of its expression in various cancers such as lung and brain cancers. The functional analysis of the LEF1-AS1 gene was conducted across multiple tissues using data from the GENT2 databases, along with meta-survival and functional enrichment analysis.
Results: The results indicated an average increase of 19.8% in DNA methylation of the promoter region of LEF1-AS1 in the samples from the smokers compared with those from the non-smokers, as well as a significant reduction of LEF1-AS1 expression level in the HUVECs (45% and 83%) after treatment with CS (3 and 6 Hours), respectively. LEF1-AS1 expression varied significantly across tumor types when compared to their normal counterparts. Some cancers, such as lung and brain, showed increased expression, suggesting cancer-specific overexpression of LEF1-AS1. Variability in expression across cancers and normal tissues implies potential heterogeneity in gene regulation. A meta-survival analysis of the LEF1-AS1 gene (e.g. GSE31546, GSE31548, GSE19188), revealed hazard ratios (HR) ranging widely, with some studies (e.g. GSE31546, HR=12.02) suggesting increased risk, though confidence intervals often included 1, indicating uncertainty. Low heterogeneity (I2=16%, p=0.26) suggests consistency among studies, but the overall findings lack strong statistical significance.
Conclusions: Our findings indicate that CS alters LEF1-AS1 DNA methylation and causes an inhibition of LEF1-AS1 expression.
Keywords: DNA methylation; HUVECs; LEF1-AS1; cigarette smoke; mRNA expression.
© 2025 Almutairi B.O. et al.
Conflict of interest statement
The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none was reported.
Figures




Similar articles
-
LncRNA LEF1-AS1/LEF1/FUT8 Axis Mediates Colorectal Cancer Progression by Regulating α1, 6-Fucosylationvia Wnt/β-Catenin Pathway.Dig Dis Sci. 2022 Jun;67(6):2182-2194. doi: 10.1007/s10620-021-07051-w. Epub 2021 May 21. Dig Dis Sci. 2022. PMID: 34021424
-
LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.Cell Cycle. 2020 Apr;19(8):870-883. doi: 10.1080/15384101.2020.1731052. Epub 2020 Mar 16. Cell Cycle. 2020. PMID: 32178558 Free PMC article.
-
Mechanism of LEF1-AS1 regulating HUVEC cells by targeting miR-489-3p/S100A11 axis.PeerJ. 2023 Nov 1;11:e16128. doi: 10.7717/peerj.16128. eCollection 2023. PeerJ. 2023. PMID: 37927791 Free PMC article.
-
Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of Tumors.Front Cell Dev Biol. 2021 Dec 20;9:750084. doi: 10.3389/fcell.2021.750084. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34988073 Free PMC article. Review.
-
LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.Biosci Rep. 2020 Aug 28;40(8):BSR20193532. doi: 10.1042/BSR20193532. Biosci Rep. 2020. PMID: 32785606 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources